Evidence map›Paper›PMID 40384848›Full record

ArticleCytotechnology2025

Network pharmacology prediction and experiment validation to discover the mechanism of

Yahui Ren, Yun Liang, Tao Zhu, Yanru Fan, Sijin Zhang, Mengmeng Zheng, Xiaoxue Xiao, Qingmin Cheng, Yue Liu, Hui Chen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cytotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yahui Ren *School of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Yun Liang *School of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Tao ZhuSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Yanru FanSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Sijin ZhangSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Mengmeng ZhengSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Xiaoxue XiaoSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Qingmin ChengSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Yue LiuSchool of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, 467044 Henan China.
Hui ChenSchool of Life Science, Yangtze University, No.1 Xueyuan Road, Jingzhou, 434022 Hubei China.
Wei SongZhengzhou Research Institute, Harbin Institute of Technology, No. 26 Longyuan East 7Th Street, Zhengdong New District, Zhengzhou, 450046 Henan China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-025-00766-y.

Indexed as

AKTLiver cancerMAPKNetwork pharmacologySophora japonica Linn.

Identifiers

PMID40384848
PMCPMC12081794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.